Expert Networks in Healthcare Investment Research: A Practical Guide

Healthcare investment is a sector where the gap between what the data shows and what is actually happening on the ground can be the difference between a great deal and a very expensive mistake. Expert networks are how the best healthcare investors close that gap.

Why healthcare investment research requires specialist primary research

Healthcare investment research is structurally different from most other sector due diligence because the variables that matter most are not visible in financial statements or management presentations. Clinical adoption rates, physician prescribing behaviour, hospital procurement committee dynamics, regulatory implementation timelines, and reimbursement trajectory are all factors that materially affect investment outcomes and that can only be reliably assessed through direct conversations with practitioners who are embedded in the relevant part of the healthcare system.

Where expert networks add the most value in healthcare investment

Physician and clinical adoption: Whether a medical technology or pharmaceutical product will achieve the adoption rates assumed in the investment model depends on physician behaviour that market data does not capture. Expert calls with practicing clinicians in the relevant specialty provide the ground-level view that financial models need.

Hospital procurement dynamics: Hospital buying committees operate according to criteria that are not fully captured in product specifications or market positioning. Expert calls with former procurement directors and hospital administrators reveal the actual decision criteria and competitive dynamics in the buying process.

Reimbursement trajectory: Whether a reimbursement rate will hold, improve, or deteriorate over the investment hold period is one of the most important variables in healthcare investment models. Expert calls with former payers, health economists, and regulatory practitioners provide the trajectory intelligence that published sources lag by months or years.

Regulatory implementation: In emerging market healthcare investments, the difference between what a regulation says and how it is implemented can be significant and consequential. Expert calls with practitioners who have navigated the implementation process in the specific jurisdiction are the only reliable source of this intelligence.

Healthcare investment research in emerging markets

Healthcare is one of the most active sectors for PE and VC investment across APAC, South Asia, and MEA, and one of the most research-intensive. The information asymmetry between what published sources describe and what practitioners experience on the ground is particularly acute in healthcare because the sector combines formal regulatory frameworks with informal implementation dynamics that vary significantly across geographies.

In India specifically, healthcare investment research requires depth that goes well below the national level. Hospital networks, diagnostic chains, and healthcare technology companies that appear to operate in a uniform national market in fact navigate significantly different regulatory implementations, physician relationship dynamics, and competitive environments across states. Expert research that does not reflect this sub-national variation is systematically incomplete.

A real example: the reimbursement call that changed a healthcare deal

A PE fund was evaluating an investment in a hospital network in South Asia with a significant proportion of revenue from government reimbursement schemes. The investment model assumed reimbursement rates would remain stable over the five-year hold period. Expert calls with two former health ministry officials and one former payer executive revealed that a policy review of reimbursement rates for the specific service lines that represented the majority of the target's reimbursement revenue had been initiated six months earlier and was widely expected within the policy community to result in rate reductions of 15 to 25 percent within eighteen months. The investment model was revised, the deal was restructured, and the fund proceeded at a materially lower valuation.

Common mistakes in healthcare investment research

Using physician opinion leaders and key opinion leaders as proxies for mainstream clinical adoption, which systematically overstates adoption rates. Not calling enough payer and regulatory experts relative to the proportion of reimbursement-dependent revenue in the investment model. Treating national-level regulatory analysis as sufficient for businesses that operate at a sub-national level where implementation varies significantly. Not refreshing primary intelligence on regulatory and reimbursement trajectory throughout the hold period.

Frequently asked questions

What types of healthcare experts are most valuable for investment due diligence? Practicing clinicians in the relevant specialty, particularly those in mainstream rather than academic settings. Former hospital procurement directors and senior administrators. Former payers and health economists. Former regulatory officials from the relevant jurisdiction. Former executives from the target company or direct competitors.

Does Nextyn have specific healthcare expert coverage in emerging markets? Yes. Healthcare is one of Nextyn's strongest sectors in India, Southeast Asia, and the GCC. Our expert network includes practicing clinicians, former health ministry officials, payer executives, and hospital administrators across these markets, with expert sourcing conducted by local teams who maintain active relationships with practitioners in the sector.

How quickly can Nextyn source healthcare experts for time-sensitive mandates? For mainstream healthcare mandates in our core markets, initial expert profiles are typically delivered within 24 to 48 hours. For highly specialised clinical or regulatory requests, 48 to 72 hours is more typical.

How Nextyn supports healthcare investment research

Nextyn has supported PE firms, venture capital funds, and corporate investors with healthcare expert network research across India, Southeast Asia, the GCC, and globally. Our healthcare coverage spans pharmaceutical, medical technology, hospital and diagnostic services, healthcare technology, and health insurance sectors. For investment firms with active or upcoming healthcare mandates, we welcome the conversation.